Clinical impact of prostate specific antigen (PSA) inter-assay variability on management of prostate cancer
Vedang Murthy(Homi Bhabha National Institute), Shyam Kishore Shrivastava(HCG Cancer Centre), Ganesh Bakshi(P. D. Hinduja Hospital and Medical Research Centre), Nitin Inamdar(Tata Memorial Hospital), Paresh B. Bhanushali, Kumar Prabhash(Homi Bhabha National Institute), Sanjeev Gupta(Banaras Hindu University), Sadhana Kannan(Homi Bhabha National Institute), Umesh Mahantshetty(Homi Bhabha National Institute), Hemant Tongaonkar(Tata Memorial Hospital), Anupam Rishi(Tata Memorial Hospital)
Cited by 24
Related Papers
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies
|Clinical and Translational Radiation Oncology|2018|932
Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study
|Radiotherapy and Oncology|2016|695
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694